Početna › Debljina › Arizona › Phoenix
Kliničke studije za Debljina u gradu Phoenix, AZ
22 studija za Debljina traži sudionike na lokacijama u gradu Phoenix i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Early Tracking of Childhood Health Determinants (ETCHED) Study
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
- NIDDK, Phoenix, Phoenix
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
U tijeku regrutacijaFaza 3
- RIO Clinical Trials - Phoenix, Phoenix
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
U tijeku regrutacijaFaza 3
- Research Site, Phoenix
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
U tijeku regrutacijaFaza 3
- Synexus Clinical Research US, Inc., Phoenix
- Medical Advancement Centers of Arizona, Phoenix
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
U tijeku regrutacijaFaza 3
- Elite Clinical Studies, LLC, Phoenix
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
- NIDDK, Phoenix, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
U tijeku regrutacijaFaza 3
- AURORA-1 Clinical Site, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
U tijeku regrutacijaFaza 3
- AURORA-2 Clinical Site, Phoenix
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
U tijeku regrutacijaFaza 3
- HonorHealth, Phoenix
- Medical Advancement Centers of Arizona, Phoenix
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
U tijeku regrutacijaFaza 2
- Helios Clinical Research - Phoenix, Phoenix
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
U tijeku regrutacijaFaza 3Zdravi dobrovoljci dobrodošli
- ACCOMPLISH-2 Research Site, Phoenix
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
U tijeku regrutacijaFaza 2
- Synexus Clinical Research US, Inc., Phoenix
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
U tijeku regrutacijaFaza 4
- Medical Dermatology Specialists, Phoenix
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
U tijeku regrutacijaFaza 3
- Kailera Clinical Site, Phoenix
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
U tijeku regrutacijaFaza 3
- Kailera Clinical Site, Phoenix
The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
- NIDDK, Phoenix, Phoenix
Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
U tijeku regrutacijaOpažajna studija
- Exponent Phoenix, Phoenix
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
U tijeku regrutacijaFaza 3
- Honor Health, Phoenix
- Arizona Research Center, Phoenix
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
U tijeku regrutacijaFaza 3
- ACCOMPLISH-1 Research Site, Phoenix
Fibrosis Lessens After Metabolic Surgery
U tijeku regrutacijaFaza 4Zdravi dobrovoljci dobrodošli
- Banner Health Center, Phoenix
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
U tijeku regrutacijaFaza 3
- Arizona Research Center, Inc., Phoenix
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
U tijeku regrutacijaFaza 3
- The University of Arizona College of Medicine- Phoenix, Phoenix
Studije za Debljina u drugim gradovima
- Houston, TX43 studija
- Chicago, IL41 studija
- New York City, NY40 studija
- San Antonio, TX40 studija
- Washington, DC33 studija
- Orlando, FL31 studija
- Dallas, TX30 studija
- Boston, MA28 studija
- Las Vegas, NV27 studija
- Miami, FL27 studija
- Baltimore, MD25 studija
- Jacksonville, FL25 studija
Ostale studije u gradu Phoenix
- Rak dojke25 studija
- Kolorektalni rak25 studija
- Nemikrocelularni karcinom pluća20 studija
- Metastatski karcinom20 studija
- Srčano zatajenje18 studija
- Rak prostate17 studija
- Rak (sve vrste)17 studija
- Multipli mijelom16 studija
- Rak gušterače16 studija
- Kardiovaskularne bolesti16 studija
- Alzheimerova bolest15 studija
- Prekomjerna tjelesna masa15 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.